SecBot SecBot
SECBOTREPLAY Home › Report › ONC

ONC · CEO John Oyler and SVP/GC Lee Chan Henry executed a cluster of…

BeOne Medicines Ltd. · CLUSTER filed Jul 24, 2026 at 16:51 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Jul 24, 2026 at 16:51 ET

CEO John Oyler and SVP/GC Lee Chan Henry executed a cluster of open-market sales totaling ~$5.4M over two days, with Oyler alone selling ~$5.0M. The sales follow large derivative exercises (non-cash) and occur at a $36.3B market cap, representing ~0.015% of market cap, well below the 0.1% materiality threshold. The cluster is dominated by the CEO, but the dollar amount is trivial relative to company size, and insider sales are weak predictors per academic literature. The cross-filing actuarial verdicts flag multiple amplifier combos, but none apply here as no earnings, restatement, offering, or late-filing context is present, this is a standalone insider cluster with no material financial impact.

  • CEO John Oyler sold ~$5.0M in open-market sales on July 20-21, 2026, following derivative exercises of 441,870 shares at $0 and 33,990 shares at $119.96.
  • SVP/GC Lee Chan Henry sold ~$542K in open-market sales on July 22, 2026, following multiple derivative exercises.
  • Total open-market sales of ~$5.4M represent ~0.015% of ONC's $36.3B market cap, well below the 0.1% materiality threshold.
  • The cluster includes non-cash derivative exercises totaling ~$4.1M (Oyler) and ~$320K (Lee) that have zero economic value.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access